Acumen Pharmaceuticals, Inc. (ABOS) Misses Q2 EPS by 9c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.45), $0.09 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Netskope (NTSK) PT Raised to $17.50 at KeyBanc
• Rithm Capital Corp. (RITM) PT Lowered to $14 at UBS on Higher for Longer Rates